Latest news with #SONNET3
Yahoo
21 hours ago
- Business
- Yahoo
Starkey and MED-EL Announce All-New DualSync Partnership to Advance Bluetooth Connectivity for Cochlear Implant Users
DURHAM, N.C., June 11, 2025--(BUSINESS WIRE)--Driven by a shared commitment to advancing hearing health, global hearing technology leaders Starkey and MED-EL are bringing their exclusive collaboration to life. Introducing DualSync, a bimodal streaming partnership enabling Apple technology to seamlessly stream to compatible Starkey hearing aids and MED-EL cochlear implants. This partnership brings together the strength of Starkey's industry-leading hearing aids with the innovation behind MED-EL's cochlear implants, creating a seamless and unified wireless audio experience for people who rely on both technologies. Beginning July 1, 2025, Starkey Edge AI and Genesis AI hearing aids and MED-EL SONNET 3, SONNET 2, SONNET, and RONDO 3 audio processors will be compatible for bimodal streaming. The solution is designed to support a growing ecosystem of devices and will be compatible with future innovations from both companies. DualSync technology provides seamless audio connectivity and synchronized sound from compatible smartphones and media devices, empowering users with more natural, connected hearing. "Hearing loss takes many forms and, in some cases, multiple technologies are required for the best outcome of the patient," said Brandon Sawalich, President and CEO of Starkey. "Today, two global tech leaders are combining world-class innovations to connect more people back to the things they love most. Partnering with MED-EL reflects our shared commitment to delivering excellence without exception." "By uniting two leading technologies, we are delivering a global solution that gives bimodal users effortless connectivity, clearer sound, and greater control in their daily lives," adds Dr. Ingeborg Hochmair, co-founder and CEO of MED-EL. "Our shared goal is simple: to make it easier for people everywhere to hear, communicate, and engage with the world – using the most advanced technology available." This collaboration reflects a shared commitment to patient-first innovation, personalized care, and expanding access to the latest in hearing technology available to users worldwide. For more information, please visit or About Starkey Starkey is a privately held, global hearing technology company headquartered in Eden Prairie, Minnesota. Founded by Bill Austin in 1967, Starkey is known for its innovative design, development and distribution of comprehensive digital hearing systems. Led today by President and CEO Brandon Sawalich, Starkey is the only American-owned provider of hearing technologies. The company has more than 5,000 employees, operates 29 facilities and does business in more than 100 markets worldwide. Learn more at About MED-EL MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by a mission to overcome hearing loss as a barrier to communication and quality of life. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair, whose ground-breaking research led to the development of the world's first micro-electronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and was the basis for what is known as the modern CI today. This laid the foundation for the successful growth of the company in 1990, when they hired their first employees. To date, MED-EL has more than 2,900 employees from around 90 nations and 30 locations worldwide. The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 137 countries enjoy the gift of hearing with the help of a MED-EL device. MED-EL's hearing solutions include cochlear and middle ear implant systems, a combined electric acoustic stimulation hearing implant system, as well as surgical and non-surgical bone conduction devices. View source version on Contacts MEDIA CONTACT: Rebecca Novak Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
21 hours ago
- Business
- Associated Press
Starkey and MED-EL Announce All-New DualSync Partnership to Advance Bluetooth Connectivity for Cochlear Implant Users
DURHAM, N.C.--(BUSINESS WIRE)--Jun 11, 2025-- Driven by a shared commitment to advancing hearing health, global hearing technology leaders Starkey and MED-EL are bringing their exclusive collaboration to life. Introducing DualSync, a bimodal streaming partnership enabling Apple technology to seamlessly stream to compatible Starkey hearing aids and MED-EL cochlear implants. This partnership brings together the strength of Starkey's industry-leading hearing aids with the innovation behind MED-EL's cochlear implants, creating a seamless and unified wireless audio experience for people who rely on both technologies. Beginning July 1, 2025, Starkey Edge AI and Genesis AI hearing aids and MED-EL SONNET 3, SONNET 2, SONNET, and RONDO 3 audio processors will be compatible for bimodal streaming. The solution is designed to support a growing ecosystem of devices and will be compatible with future innovations from both companies. DualSync technology provides seamless audio connectivity and synchronized sound from compatible smartphones and media devices, empowering users with more natural, connected hearing. 'Hearing loss takes many forms and, in some cases, multiple technologies are required for the best outcome of the patient,' said Brandon Sawalich, President and CEO of Starkey. 'Today, two global tech leaders are combining world-class innovations to connect more people back to the things they love most. Partnering with MED-EL reflects our shared commitment to delivering excellence without exception.' 'By uniting two leading technologies, we are delivering a global solution that gives bimodal users effortless connectivity, clearer sound, and greater control in their daily lives,' adds Dr. Ingeborg Hochmair, co-founder and CEO of MED-EL. 'Our shared goal is simple: to make it easier for people everywhere to hear, communicate, and engage with the world – using the most advanced technology available.' This collaboration reflects a shared commitment to patient-first innovation, personalized care, and expanding access to the latest in hearing technology available to users worldwide. For more information, please visit or About Starkey Starkey is a privately held, global hearing technology company headquartered in Eden Prairie, Minnesota. Founded by Bill Austin in 1967, Starkey is known for its innovative design, development and distribution of comprehensive digital hearing systems. Led today by President and CEO Brandon Sawalich, Starkey is the only American-owned provider of hearing technologies. The company has more than 5,000 employees, operates 29 facilities and does business in more than 100 markets worldwide. Learn more at About MED-EL MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by a mission to overcome hearing loss as a barrier to communication and quality of life. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair, whose ground-breaking research led to the development of the world's first micro-electronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and was the basis for what is known as the modern CI today. This laid the foundation for the successful growth of the company in 1990, when they hired their first employees. To date, MED-EL has more than 2,900 employees from around 90 nations and 30 locations worldwide. The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 137 countries enjoy the gift of hearing with the help of a MED-EL device. MED-EL's hearing solutions include cochlear and middle ear implant systems, a combined electric acoustic stimulation hearing implant system, as well as surgical and non-surgical bone conduction devices. View source version on CONTACT: MEDIA CONTACT: Rebecca Novak Tibbitt [email protected] KEYWORD: UNITED STATES NORTH AMERICA NORTH CAROLINA INDUSTRY KEYWORD: TECHNOLOGY MEDICAL DEVICES OTHER TECHNOLOGY HEALTH TECHNOLOGY AUDIO/VIDEO OTHER HEALTH HARDWARE HEALTH GENERAL HEALTH SOURCE: MED-EL Copyright Business Wire 2025. PUB: 06/11/2025 07:57 AM/DISC: 06/11/2025 07:55 AM
Associated Press
14-02-2025
- Business
- Associated Press
MED-EL USA Announces FDA Approval of SONNET 3 Audio Processor with Built-In Direct Streaming, Compact Design and Enhanced Features
MED-EL USA announced today that the U.S. Food and Drug Administration approved the new SONNET 3 audio processor for MED-EL cochlear implants. SONNET 3 is the company's lightest and smallest behind-the-ear audio processor and features integrated wireless direct streaming capabilities. Superior hearing performance has always been at the forefront of MED-EL hearing implants. SONNET 3's ASM 3.0 technology automatically adjusts the processor's settings to match the environment. This includes reducing distracting background noises and leveraging dual microphones to allow users to focus on conversations. The device supports binaural streaming, where bilateral users can pair two SONNET 3 processors or a SONNET 3 and another audio processor with AudioStream to enjoy their best hearing and streaming. Music and phone calls can be streamed directly from compatible devices, including Android and Apple. In addition, SONNET 3 users can stream audio directly from compatible smart TVs and digital media players, free from wires or additional devices. SONNET 3 also features a convenient Touch Key for changing programs, a flexible earhook for maximum comfort, and a waterproof IP68 design for water adventures – all while providing users with superior hearing performance. 'We are thrilled to introduce SONNET 3 to our current cochlear implant users and candidates in the United States. Our smallest and lightest behind-the-ear audio processor with built-in direct streaming is ready to fit seamlessly into everyday life. In addition to comfort and convenience, SONNET 3 offers the superior hearing performance that MED-EL is known for,' said John Sparacio, President and CEO of MED-EL USA. At 2.0g lighter and over 18% shorter than SONNET 2 with AudioStream, SONNET 3 is MED-EL's smallest behind-the-ear audio processor. The compact design brings users the right combination of comfort and convenience to enjoy sound effortlessly. SONNET 3 is expected to become available in early 2025. However, with MED-EL USA's TechSwap Program, there is no need to wait for future technology. As of September 1, 2024, patients who receive a MED-EL cochlear implant can exchange one audio processor for the SONNET 3. About MED-EL MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by its mission to overcome hearing loss as a barrier to communication and quality of life. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair. Their ground-breaking research led to the development of the world's first micro-electronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and became the basis for the modern CI today. The company hired its first employees in 1990 and has since grown to more than 2,900 employees across 90 nations and 30 locations worldwide. The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 137 countries to enjoy the gift of hearing with the help of a MED-EL device. MED-EL's hearing solutions include cochlear and middle ear implant systems, a combined electric acoustic stimulation hearing implant system, as well as surgical and non-surgical bone conduction devices. [email protected] SOURCE: MED-EL USA Copyright Business Wire 2025. PUB: 02/14/2025 12:34 PM/DISC: 02/14/2025 12:34 PM
